Expression of RANTES mRNA and protein in airways of patients with mild asthma
Expression of RANTES mRNA and protein in airways of patients with mild asthma
复制标题
DOI:
10.1164/ajrccm.154.6.8970374
复制
发表时间:
1996-12-01
影响因子:
24.7
通讯作者:
Chung, KF
中科院分区:
文献类型:
--
作者:
Berkman, N;Krishnan, VL;Chung, KF
Chemoattractant cytokines (chemokines) such as RANTES, are potent chemoattractants for eosinophils, T lymphocytes, and monocyte/macrophages. We examined RANTES mRNA and protein expression in bronchial biopsies and bronchoalveolar lavage (BAL) cells from patients with mild asthma on beta(2)-adrenergic agonist therapy only. Using quantitative polymerase chain reaction (PCR), mean RANTES starting cDNA was 110 +/- 18 fg/pg beta-actin in asthmatics compared with 33.7 +/- 11.0 fg/pg in normals (p < 0.003) but there was no significant difference in RANTES mRNA expression in BAL cells between the two groups. Immunohistochemical staining of cryostat sections of bronchial biopsies with an anti-RANTES antibody using peroxidase antiperoxidase method revealed constitutive staining in airway epithelial cells, airway smooth muscle and subepithelial cells. However, there was no difference in the number of RANTES-staining cells between normal subjects and asthmatics despite significantly increased numbers of CD4(+) T-cells, CD68(+) macrophages, and MBP(+) eosinophils in mucosal biopsies obtained from asthmatics. Double-staining revealed expression of RANTES in proportion of CD3(+) T lymphocytes. Thus, RANTES is constitutively expressed in the airways and RANTES mRNA is elevated in airways of patients with mild asthma, supporting a role for RANTES in normal and asthmatic airways.